No abstract available
Keywords:
Food and Drug Administration; decision making; end stage kidney disease; patient engagement; patient preference; patient-reported outcomes; regulatory.
MeSH terms
-
Clinical Decision-Making*
-
Equipment and Supplies*
-
Humans
-
Kidney Diseases / therapy*
-
Patient Participation*
-
Patient Preference*
-
Therapies, Investigational*